标题
Drugs in development for chronic hepatitis C: a promising future
作者
关键词
-
出版物
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 11, Issue 12, Pages 1611-1622
出版商
Informa Healthcare
发表日期
2011-11-03
DOI
10.1517/14712598.2011.627851
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Telaprevir Alone or With Peginterferon and Ribavirin Reduces HCV RNA in Patients With Chronic Genotype 2 but Not Genotype 3 Infections
- (2011) Graham R. Foster et al. GASTROENTEROLOGY
- Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells
- (2011) Itziar Echeverria et al. HEPATOLOGY
- 1359 FIRST SVR DATA WITH THE NUCLEOSIDE ANALOGUE POLYMERASE INHIBITOR MERICITABINE (RG7128) COMBINED WITH PEGINTERFERON/RIBAVIRIN IN TREATMENT-NAIVE HCV G1/4 PATIENTS: INTERIM ANALYSIS FROM THE JUMP-C TRIAL
- (2011) P. Pockros et al. JOURNAL OF HEPATOLOGY
- 12 IL28B POLYMORPHISM PREDICTS VIROLOGIC RESPONSE IN PATIENTS WITH HEPATITIS C GENOTYPE 1 TREATED WITH BOCEPREVIR (BOC) COMBINATION THERAPY
- (2011) F. Poordad et al. JOURNAL OF HEPATOLOGY
- 13 SIMILAR SVR RATES IN IL28B CC, CT OR TT PRIOR RELAPSER PARTIAL- OR NULL-RESPONDER PATIENTS TREATED WITH TELAPREVIR/PEGINTERFERON/RIBAVIRIN: RETROSPECTIVE ANALYSIS OF THE REALIZE STUDY
- (2011) S. Pol et al. JOURNAL OF HEPATOLOGY
- 1356 QUADRUPLE THERAPY WITH BMS-790052, BMS-650032 AND PEG-IFN/RBV FOR 24 WEEKS RESULTS IN 100% SVR12 IN HCV GENOTYPE 1 NULL RESPONDERS
- (2011) A. Lok et al. JOURNAL OF HEPATOLOGY
- 8 EVOLUTION OF TREATMENT-EMERGENT RESISTANT VARIANTS IN TELAPREVIR PHASE 3 CLINICAL TRIALS
- (2011) J.C. Sullivan et al. JOURNAL OF HEPATOLOGY
- 1372 ONCE DAILY PSI-7977 PLUS PEG-IFN/RBV IN HCV GT1: 98% RAPID VIROLOGIC RESPONSE, COMPLETE EARLY VIROLOGIC RESPONSE: THE PROTON STUDY
- (2011) D.R. Nelson et al. JOURNAL OF HEPATOLOGY
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
- (2011) Kenneth E. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Retreatment of HCV Infection
- (2011) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Variants in the ITPA Gene Protect Against Ribavirin-Induced Hemolytic Anemia and Decrease the Need for Ribavirin Dose Reduction
- (2010) Alexander J. Thompson et al. GASTROENTEROLOGY
- Telaprevir Is Effective Given Every 8 or 12 Hours With Ribavirin and Peginterferon Alfa-2a or -2b to Patients With Chronic Hepatitis C
- (2010) Patrick Marcellin et al. GASTROENTEROLOGY
- Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype
- (2010) Alexander J. Thompson et al. HEPATOLOGY
- Potential role for Interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection
- (2010) Jason Grebely et al. HEPATOLOGY
- NS5A inhibitors: A new breakthrough for the treatment of chronic hepatitis C
- (2010) Tarik Asselah JOURNAL OF HEPATOLOGY
- A perspective on modelling hepatitis C virus infection
- (2010) J. Guedj et al. JOURNAL OF VIRAL HEPATITIS
- Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial
- (2010) Edward J Gane et al. LANCET
- Telaprevir for Previously Treated Chronic HCV Infection
- (2010) John G. McHutchison et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cyclophilin Inhibitors
- (2009) Philippe A. Gallay Clinics in Liver Disease
- Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression
- (2009) Gary L. Davis et al. GASTROENTEROLOGY
- Resistance to Direct Antiviral Agents in Patients With Hepatitis C Virus Infection
- (2009) Christoph Sarrazin et al. GASTROENTEROLOGY
- The cyclophilin inhibitor Debio 025 combined with PEG IFNα2a significantly reduces viral load in treatment-naïve hepatitis C patients
- (2009) Robert Flisiak et al. HEPATOLOGY
- The global burden of hepatitis C
- (2009) Daniel Lavanchy LIVER INTERNATIONAL
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- (2009) Dongliang Ge et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search